1INN — innoscripta SE Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | DEMm | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
innoscripta SE, formerly innoscripta AG, is a Germany-based software company. The Company is specialized in cloud-based compliance software for research and development. It operates as a funding consulting and support companies from a wide range of industries in managing and documenting their research and development (R&D) projects while securing funding. It is engaged in development and distribution of software as a service (SaaS) solution for the research and development process, which includes project management software, software for time recording, software for employee management and the creation of data interfaces to third-party systems. The Company's platform offers solutions that support customers in identifying, validating and managing R&D projects and ensure reliable and compliant documentation for R&D tax credits.
Directors
- Last Annual
- Last Interim
- Incorporated
- June 5th, 2012
- Public Since
- May 21st, 2025
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Munich Stock Exchange
- Address
- Arnulfstrasse 60, MUENCHEN, 80335
- Web
- https://www.innoscripta.com/
- Phone
- +49 89255553537
- Auditors
Upcoming Events for 1INN
Similar to 1INN
Backbone Technology AG
Munich Stock Exchange
Performance One AG
Munich Stock Exchange
Rubean AG
Munich Stock Exchange
Securize IT Solutions AG
Munich Stock Exchange
Stock3 AG
Munich Stock Exchange
FAQ
As of Today at 21:18 UTC, shares in innoscripta SE are trading at . This share price information is delayed by 15 minutes.
Shares in innoscripta SE last closed at and the price had moved by over the past 365 days. In terms of relative price strength the innoscripta SE share price has matched the FTSE Global All Cap Index by over the past year.
There is no consensus recommendation for this security.
Find out moreinnoscripta SE does not currently pay a dividend.
innoscripta SE does not currently pay a dividend.
innoscripta SE does not currently pay a dividend.
To buy shares in innoscripta SE you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of , shares in innoscripta SE had a market capitalisation of .
Here are the trading details for innoscripta SE:
- Country of listing: Germany
- Exchange: MUN
- Ticker Symbol: 1INN
Based on an overall assessment of its quality, value and momentum innoscripta SE is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like innoscripta SE. Over the past six months, its share price has matched the FTSE Global All Cap Index by .
As of the last closing price of , shares in innoscripta SE were trading -2.58% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The innoscripta SE PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at .
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on innoscripta SE's directors